Published, Version of Record (VoR)CC BY V4.0, Open
Abstract
Biochemistry & Molecular Biology Chemistry, Medicinal Food Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology ESI Highly Cited Paper (Incites)
Inflammation has been reported to be intimately linked to the development or worsening of several non-infectious diseases. A number of chronic conditions such as cancer, diabetes, cardiovascular disorders, autoimmune diseases, and neurodegenerative disorders emerge as a result of tissue injury and genomic changes induced by constant low-grade inflammation in and around the affected tissue or organ. The existing therapies for most of these chronic conditions sometimes leave more debilitating effects than the disease itself, warranting the advent of safer, less toxic, and more cost-effective therapeutic alternatives for the patients. For centuries, flavonoids and their preparations have been used to treat various human illnesses, and their continual use has persevered throughout the ages. This review focuses on the anti-inflammatory actions of flavonoids against chronic illnesses such as cancer, diabetes, cardiovascular diseases, and neuroinflammation with a special focus on apigenin, a relatively less toxic and non-mutagenic flavonoid with remarkable pharmacodynamics. Additionally, inflammation in the central nervous system (CNS) due to diseases such as multiple sclerosis (MS) gives ready access to circulating lymphocytes, monocytes/macrophages, and dendritic cells (DCs), causing edema, further inflammation, and demyelination. As the dearth of safe anti-inflammatory therapies is dire in the case of CNS-related disorders, we reviewed the neuroprotective actions of apigenin and other flavonoids. Existing epidemiological and pre-clinical studies present considerable evidence in favor of developing apigenin as a natural alternative therapy against chronic inflammatory conditions.
Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
Creators
Rashida Ginwala - Drexel University, Microbiology and Immunology
Raina Bhavsar - Drexel University, Microbiology and Immunology
De Gaulle I. Chigbu - Drexel University, Microbiology and Immunology
Pooja Jain - Drexel University
Zafar K. Khan - Drexel University
Publication Details
Antioxidants, v 8(2)
Publisher
MDPI
Number of pages
28
Grant note
R01 NS097147 / NIH/NINDS; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
R01NS097147 / NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)
Resource Type
Journal article
Language
English
Academic Unit
Microbiology and Immunology; Pennsylvania College of Optometry (PCO)
Web of Science ID
WOS:000460695700007
Scopus ID
2-s2.0-85062353094
Other Identifier
991019167878804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool: